Literature DB >> 24073712

Bordetella pertussis seroprevalence in Belgian adults aged 20-39 years, 2012.

K Huygen1, C Rodeghiero1, D Govaerts2, I Leroux-Roels3, P Melin4, M Reynders5, S Van Der Meeren6, S Van Den Wijngaert7, D Pierard6.   

Abstract

SUMMARY The last report on pertussis seroprevalence in Belgium concerned samples collected during 1993-1994. In the context of the Eupert-Labnet WP6 seroprevalence study (comparing sera from 16 European member states), 1500 anonymized leftover diagnostic samples were collected randomly during the second semester of 2012 by the clinical chemistry laboratories of six participating Belgian centres, distributed equally between Flanders, Wallonia and Brussels Capital Region. As suggested by the WP6 organizers, a total of 750 samples (125/centre) were selected from subjects in the 20-29 years age group and 750 samples (125/centre) from subjects in the 30-39 years age group. Anti-PT IgG levels were measured using Virion-Serion ELISA and analysed using predefined cut-off levels. Sixty-one (4%) sera were indicative of an infection in the past 2 years (between 50 and 100 IU/ml) and another 61 (4%) sera had anti-PT IgG antibodies reflecting acute infection (>100 IU/ml). These results highlight the presence of a Bordetella pertussis reservoir in the adult 'healthy' Belgian population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24073712      PMCID: PMC9151172          DOI: 10.1017/S0950268813002458

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  14 in total

1.  Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium).

Authors:  Marie Van der Wielen; Pierre Van Damme; Koen Van Herck; Susanna Schlegel-Haueter; Claire-Anne Siegrist
Journal:  Vaccine       Date:  2003-06-02       Impact factor: 3.641

2.  Pertussis: increasing disease as a consequence of reducing transmission.

Authors:  Ricardo Aguas; Guilherme Gonçalves; M Gabriela M Gomes
Journal:  Lancet Infect Dis       Date:  2006-02       Impact factor: 25.071

3.  Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children.

Authors:  Hans O Hallander; Margaretha Ljungman; Jann Storsaeter; Lennart Gustafsson
Journal:  APMIS       Date:  2009-11       Impact factor: 3.205

4.  Pertussis serodiagnosis in Belgium from 1990 to 2009.

Authors:  Muriel Vincent; Caroline Rodeghiero; Romain Eylenbosch; Yvan Mans; Jeannine Swalus-Steenhouwer; Denis Piérard; Kris Huygen; Raymond Vanhoof
Journal:  Clin Vaccine Immunol       Date:  2011-02-23

Review 5.  Rationale for pertussis booster vaccination throughout life in Europe.

Authors:  Fred Zepp; Ulrich Heininger; Jussi Mertsola; Ewa Bernatowska; Nicole Guiso; John Roord; Alberto E Tozzi; Pierre Van Damme
Journal:  Lancet Infect Dis       Date:  2011-05-18       Impact factor: 25.071

6.  Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines.

Authors:  P Olin; F Rasmussen; L Gustafsson; H O Hallander; H Heijbel
Journal:  Lancet       Date:  1997-11-29       Impact factor: 79.321

7.  New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative.

Authors:  Kevin D Forsyth; Magda Campins-Marti; Jaime Caro; James D Cherry; David Greenberg; Nicole Guiso; Ulrich Heininger; Joop Schellekens; Tina Tan; Carl-Heinz Wirsing von König; Stanley Plotkin
Journal:  Clin Infect Dis       Date:  2004-11-18       Impact factor: 9.079

Review 8.  Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy.

Authors:  K E Wiley; Y Zuo; K K Macartney; P B McIntyre
Journal:  Vaccine       Date:  2012-11-29       Impact factor: 3.641

Review 9.  Maternal immunization: an update for pediatricians.

Authors:  Flor M Munoz
Journal:  Pediatr Ann       Date:  2013-08       Impact factor: 1.132

10.  Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis.

Authors:  Sabine C de Greeff; Hester E de Melker; Pieter G M van Gageldonk; Joop F P Schellekens; Fiona R M van der Klis; Liesbeth Mollema; Frits R Mooi; Guy A M Berbers
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

View more
  9 in total

Review 1.  Bordetella pertussis evolution in the (functional) genomics era.

Authors:  Thomas Belcher; Andrew Preston
Journal:  Pathog Dis       Date:  2015-08-21       Impact factor: 3.166

Review 2.  Immune persistence after pertussis vaccination.

Authors:  Zhiyun Chen; Qiushui He
Journal:  Hum Vaccin Immunother       Date:  2017-01-03       Impact factor: 3.452

3.  [Pertussis diagnosis: the limitation of the currently used criteria and the suggestion of Global Pertussis Initiative].

Authors:  Kai-Hu Yao; Ji-Kui Deng; Rexiati Dawuti
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2016-09

4.  Development of a Dot-Blot Assay for the Detection of Mould-Specific IgE in the Belgian Population.

Authors:  Muriel Vincent; Marta Romano; Francis Corazza; Kris Huygen; Olivier Michel; Olivier Denis
Journal:  Mycopathologia       Date:  2016-11-22       Impact factor: 2.574

5.  Pertussis diagnosis in Belgium: results of the National Reference Centre for Bordetella anno 2015.

Authors:  H Martini; C Rodeghiero; C VAN DEN Poel; M Vincent; D Pierard; K Huygen
Journal:  Epidemiol Infect       Date:  2017-06-05       Impact factor: 4.434

6.  A Belgian Serosurveillance/Seroprevalence Study of Diphtheria, Tetanus and Pertussis Using a Luminex xMAP Technology-Based Pentaplex.

Authors:  Raissa Nadège Caboré; Denis Piérard; Kris Huygen
Journal:  Vaccines (Basel)       Date:  2016-05-10

7.  Seroprevalence of Bordetella pertussis antibodies in adults in Hungary: results of an epidemiological cross-sectional study.

Authors:  Péter Torzsa; Raghavendra Devadiga; Monica Tafalla
Journal:  BMC Infect Dis       Date:  2017-04-04       Impact factor: 3.090

8.  Aetiology of lower respiratory tract infection in adults in primary care: a prospective study in 11 European countries.

Authors:  M Ieven; S Coenen; K Loens; C Lammens; F Coenjaerts; A Vanderstraeten; B Henriques-Normark; D Crook; K Huygen; C C Butler; T J M Verheij; P Little; K Zlateva; A van Loon; E C J Claas; H Goossens
Journal:  Clin Microbiol Infect       Date:  2018-02-12       Impact factor: 8.067

9.  Investigating Bordetella pertussis colonisation and immunity: protocol for an inpatient controlled human infection model.

Authors:  Hans de Graaf; Diane Gbesemete; Andrew R Gorringe; Dimitri A Diavatopoulos; Kent E Kester; Saul N Faust; Robert C Read
Journal:  BMJ Open       Date:  2017-10-11       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.